Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06372613

Association Between LRG and Histologic Remission in Ulcerative Colitis

Sponsor: Showa Inan General Hospital

View on ClinicalTrials.gov

Summary

We attempt to clarify the serum leucine-rich α 2-glycoprotein (LRG) level which can predict histologic remission in ulcerative colitis patients in this study. Colonoscopy with histology will be performed when histologic remission is predicted, irrespective of symptoms or serum LRG values. Serum LRG levels are analyzed by an enzyme-linked immunosorbent assay.

Official title: What is the Level of Serum Leucine-rich α 2-glycoprotein (LRG) Which Predicts Histologic Remission in Patients With Ulcerative Colitis?

Key Details

Gender

All

Age Range

20 Years - 90 Years

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2024-02-25

Completion Date

2025-12-31

Last Updated

2025-08-22

Healthy Volunteers

Not specified

Locations (1)

Showa Inan General Hospital

Komagane, Japan